RDNT RadNet Inc.

RadNet Inc.

Medical Specialities

Health Care

RadNet, Inc., together with its subsidiaries, provides outpatient diagnostic imaging services in the United States. Its services include magnetic resonance imaging, computed tomography, positron emission tomography, nuclear medicine, mammography, ultrasound, diagnostic radiology, fluoroscopy, and other related procedures, as well as multi-modality imaging services. The company also develops and sells computerized systems for the diagnostic imaging industry, including picture archiving communications systems. As of March 8, 2021, it owned and/or operated 331 centers in Arizona, California, Delaware, Florida, Maryland, New Jersey, and New York. The company was founded in 1985 and is headquartered in Los Angeles, California.

IPO Year:

Exchange: NASDAQ

Website: radnet.com

Recent Analyst Ratings for RadNet Inc.

Date	Price Target	Rating	Analyst
6/13/2025	$69.00	Buy	B. Riley Securities
3/5/2025	$85.00 → $65.00	Outperform → Strong Buy	Raymond James
9/6/2024	$57.00 → $79.00	Equal Weight → Overweight	Barclays
3/6/2024	$48.00	Equal Weight	Barclays
8/31/2023	$40.00	Buy	Truist
3/31/2023	$30.00	Market Outperform	CJS Securities
3/3/2023	$30.00	Mkt Perform → Outperform	Raymond James
8/12/2021		Outperform → Market Perform	Raymond James
8/12/2021	$39.00	Overweight	Barclays

See more ratings

RadNet Inc.

Recent Analyst Ratings for RadNet Inc.

RadNet Inc. Insider Trading

Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

EVP, Chief Science Officer Sorensen Alma Gregory gifted 5,600 shares, decreasing direct ownership by 0.48% to 1,165,345 units (SEC Form 4)

Director Swartz David L was granted 2,699 shares, increasing direct ownership by 2% to 176,766 units (SEC Form 4)

Director Spurlock Gregory E. was granted 2,699 shares, increasing direct ownership by 104% to 5,290 units (SEC Form 4)

Director Levitt Lawrence L was granted 2,699 shares, increasing direct ownership by 2% to 167,656 units (SEC Form 4)

Director Jacobs Laura Pastre was granted 2,699 shares, increasing direct ownership by 11% to 27,007 units (SEC Form 4)

EVP, Mergers and Acquisitions Murdock Michael N sold $646,213 worth of shares (11,132 units at $58.05), decreasing direct ownership by 21% to 43,084 units (SEC Form 4)

EVP, Chief Science Officer Sorensen Alma Gregory was granted 10,436 shares, increasing direct ownership by 0.90% to 1,170,945 units (SEC Form 4)

EVP, Chief Science Officer Sorensen Alma Gregory sold $5,674,100 worth of shares (100,000 units at $56.74), decreasing direct ownership by 8% to 1,160,509 units (SEC Form 4)

Pres & COO-Eastern Operations Forthuber Stephen M converted options into 2,760 shares and sold $1,135,599 worth of shares (18,820 units at $60.34), decreasing direct ownership by 3% to 535,182 units (SEC Form 4)

Director Levitt Lawrence L sold $305,450 worth of shares (5,000 units at $61.09), decreasing direct ownership by 3% to 164,957 units (SEC Form 4)